Silibinin component for the treatment of hepatitis

The invention relates to the use of a silibinin component for the production of a medicament that is adapted for parenteral administration for the treatment of viral hepatitis, preferably of hepatitis B or C, in particular for the reduction of the virus load. The medicament preferably contains no si...

Full description

Saved in:
Bibliographic Details
Main Authors D'AMATO MASSIMO MARIA, FERENCI PETER, POHL RALF-TORSTEN, ROVATI LUCIO CLAUDIO, MENGS ULRICH
Format Patent
LanguageEnglish
Published 02.02.2016
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The invention relates to the use of a silibinin component for the production of a medicament that is adapted for parenteral administration for the treatment of viral hepatitis, preferably of hepatitis B or C, in particular for the reduction of the virus load. The medicament preferably contains no silidianin and/or no silichristin and/or no isosilibinin.
Bibliography:Application Number: US201313871045